March 19, 2018 by Bill Schiffner
drug development, health care cost, IQVIA Institute for Human Data Science, Murray Aitken, specialty medicines market, telehealth
2018, Issue 03-19-2018, Issues, News
DANBURY, Conn. — The types of medicines being developed, the way technology contributes to health and how the value of health is calculated are all changing dramatically, according to a new report from the IQVIA Institute for Human Data Science. The IQVIA study, “2018 and Beyond: Outlook and Turning Points,” looks at several health care
March 13, 2018 by Bill Schiffner
2018 and Beyond: Outlook and Turning Points, global drug spending, IQVIA Institute for Human Data Science, Murray Aitken
Leading Headlines, Pharmacy, Retail News

DANBURY, Conn. — The types of medicines being developed, the way technology contributes to health and how the value of health is calculated are all changing dramatically, according to a new report from the IQVIA Institute for Human Data Science. The study, “2018 and Beyond: Outlook and Turning Points,” looks at trends health care and
November 13, 2017 by CDR Blog and Chain Drug Review
digital health, Growing Value of Digital Health, health-related mobile apps, IQVIA Institute for Human Data Science, mobile health apps, mobile health technology, Murray Aitken, wearables
CDR Blog

There’s no slowing down the proliferation of mobile health technology. Currently, consumers can choose from more than 318,500 health-related mobile apps — almost double the number two years ago — and about 200 new apps are launched daily. What’s more, over 340 consumer wearable devices are now on the market globally. And supporting the burgeoning
December 6, 2016 by Chain Drug Review
global drug spending, Murray Aitken, Outlook for Global Medicines Through 2021: Balancing Cost and Value, QuintilesIMS Institute, worldwide spending on medicines
Leading Headlines, Pharmacy, Retail News

DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Though annual growth stands to moderate, global drug spending will climb to an estimated $1.5 trillion by 2021, up 33% from this year, according to the QuintilesIMS Institute. Worldwide spending on medicines is projected to grow at a 4% to 7% compound annual rate over the next
April 14, 2016 by John Schultz and Chain Drug Review
health care costs, IMS Institute for Healthcare Informatics, Medicines Use and Spending in the U.S., Murray Aitken, prescription drug spending, specialty drug spending, U.S. spending on medicines
2016, Featured Articles, Issue 04-18-2016, Issues, Leading Headlines, News, Pharmacy, Retail News

PARSIPPANY, N.J. — Growth in spending on medicines dipped last year, but that hasn’t eased the challenge of balancing access to drugs and the cost of care in an era of innovative but more expensive treatments, according to the IMS Institute for Healthcare Informatics. For the second year, medication spending climbed by double digits in
November 18, 2015 by John Schultz and Chain Drug Review
global drug spending, global medicine use, global spend for pharmaceuticals, IMS Health, IMS Institute for Healthcare Informatics, Murray Aitken, prescription drug usage
Leading Headlines, Pharmacy, Supplier News

DANBURY, Conn. — More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31% a decade ago, as the “medicine use gap” between developed and pharmerging markets narrows, the IMS Institute for Healthcare Informatics projects. Global drug spending is